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Reply to C. Falci et al
We thank Falci et al1 for their comments, which give us an
opportunity todiscuss someof themethodologic aspectsofour study2
in greater detail. We are also interested to see the final results of their
similar trial,3 because the analysis of preliminary findings of an ongo-
ing study can sometimes be misleading.
A major issue is certainly the method of administering Vul-
nerable Elders Survey-13 (VES-13) and comprehensive geriatric
assessment (CGA). Because elderly patients often have difficulty in
completing a self-reported questionnaire such as VES-13,4 we em-
ployed a physician-assisted assessment, even though this undoubt-
edly affected the time-saving characteristics of the questionnaire
itself. To minimize possible investigator-related biases, CGA was
administered by an independent physician before any other ques-
tionnaire, including VES-13.
Another aspectworth considering is the choice of the activities of
daily living (ADLs)—and even more so the instrumental ADLs
(IADLs)—score indicating state of dependency, which is particularly
important, because it influencespatients’ subsequent clinicalmanage-
ment. Because there is a lack of conclusive data from prospective
investigations, we decided to adopt the criteria of Bernardi et al,5 who
used an IADL cutoff value of five or fewer regardless of sex as defining
the need for tailored treatment. In our experience, physician-guided
administration of IADLs makes it possible to assess appropriately
activities such as cooking and doing the laundry, which men are
potentially capable of doing even if theyoftendonot actually do them.
It is for this reason that we believe a cutoff value of four can underes-
timate the frequency of disability inmen. As far as the possible impact
of tumor stage on VES-13 is concerned, although our study popula-
tionwascorrectly sized in relation topre-establishedobjectives,wedid
not make any subgroup analyses (eg, on the basis of tumor stage) to
avoid inconsistencies resulting frominadequate sample size.Although
ahigherprevalenceofdisability hasbeen reported in similar studies,6,7
the 419 consecutive unselected patients assessed in an oncologic de-
partment of a general hospital in our series2 were likely representative
ofoururbanarea.The satisfactory sensitivity and specificityofVES-13
we reportedweremore likely to have resulted from the characteristics
of the instrument itself than from the patient mix of the sample. The
negative predictive value, which is an essential requirement for a
reliable screening tool,was high (91.2%), suggesting the validity of the
test in this setting.
In conclusion, we agree that clinicians should be cautious when
usingVES-13 as a substitute forCGA.On thebasis of ourfindings and
as stated in our report,2 we believe thatVES-13 should instead be used
as a screening tool to evaluate the functional status of elderly patients
with cancer.
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